Could halting antibiotic distributions end trachoma for good?
NCT ID NCT06289647
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if communities with low levels of trachoma could stop receiving yearly azithromycin treatments without the infection coming back. Researchers planned to compare groups that continued or stopped the medicine over three years. However, the trial was withdrawn before any participants were enrolled, so no conclusions can be drawn.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- azithromycin
- What this could lead to
- If successful, this could show that annual mass treatment can be safely stopped in low-infection areas, helping to eliminate trachoma more efficiently.
- What could go wrong
- The trial was withdrawn before enrolling any participants, so no results are available. It is unclear if stopping treatment would cause trachoma to return.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRACHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California, San Francisco
Kindu, Maniema Province, Democratic Republic of the Congo
More trials for these conditions
Other studies related to the condition(s) this trial covers.